Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Iceland Entertainment Insider.
The Hidden Vegetables Cookbook Offers a New Approach to Healthy Eating Without the Stigma
Sioux Falls, SD, Sept. 05, 2025 (GLOBE NEWSWIRE) -- A new cookbook is turning traditional advice about eating vegetables on its head. The Hidden Vegetables Cookbook: 90 Tasty Recipes for Veggie-Averse Adults by author Heidi Herman provides a fresh...
'Let’s Walk' with Halli: A Podcast Designed to Spark Creativity—One Conversation at a Time
REYKJAVíK, ICELAND, June 24, 2025 /EINPresswire.com/ -- What happens when you take creativity outside, strip away the scripts, and let the world set the pace? You get Let’s Walk—a new biweekly podcast from Icelandic designer and entrepreneur...
Century Aluminum Signs Power Agreement Extension with Santee Cooper Through 2031
CHICAGO, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Century Aluminum Company (NASDAQ:CENX) has signed an extension of its power agreement with South Carolina Public Service Authority (Santee Cooper) to secure a stable power supply for its Mt. Holly smelter...
Alvotech Appoints Linda Jónsdóttir as Chief Financial Officer
REYKJAVIK, Iceland, July 10, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the appointment of Linda...
Alvotech Expands its Capacity in Assembly and Packaging with the Acquisition of Ivers-Lee in Switzerland
REYKJAVIK, Iceland and BURGDORF, Switzerland, July 09, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the...
Alvotech Announces Webcast to Report Financial Results for the First Half of 2025 on August 14, 2025, at 8:00 am EDT
REYKJAVIK, Iceland, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced today that it will release financial...
Oculis and EURETINA Announce the Winner of the Ramin Tadayoni Award 2025
ZUG, Switzerland, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on innovations for ophthalmic and neuro-ophthalmic diseases with significant unmet medical...
Alvotech and Advanz Pharma Enter into European Supply and Commercialization Agreement for Biosimilar Candidate to Cimzia® (certolizumab pegol)
REYKJAVIK, Iceland and LONDON, July 01, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma Holdco Limited...
Oculis to Present Clinical Trial Results in Diabetic Macular Edema and Acute Optic Neuritis at Ophthalmology Conferences
Phase 2 ACUITY trial results for Privosegtor (OCS-05) in acute optic neuritis to be presented in EURETINA late-breaking session Expanded data analysis from Phase 3 Stage 1 DIAMOND program for OCS-01 eye drops in diabetic macular edema (DME) to be...
Alvotech’s Lenders Lower Interest on Senior Secured Term Loan Facility
REYKJAVIK, Iceland, June 26, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO, the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that its lenders...
CLEAR+ Enrollment Now Available to More International Travelers for Seamless Airport Journeys
NEW YORK, Oct. 02, 2025 (GLOBE NEWSWIRE) -- CLEAR (NYSE: YOU), the secure identity company, today announced the expansion of CLEAR+ enrollment, enabling travelers from 40 countries across Europe, Asia, and the Americas to join CLEAR+ and enjoy a...
Positive Top Line Results from Confirmatory Efficacy Study for Proposed Biosimilar to Xolair® (omalizumab)
REYKJAVIK, Iceland and PISCATAWAY, N.J. and LONDON, June 25, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacturing of biosimilar medicines for patients worldwide, Kashiv...
European Medicines Agency Recommends Market Approval of AVT06, Alvotech’s Proposed Biosimilar to Eylea® (aflibercept)
REYKJAVIK, Iceland and LONDON, June 23, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma, a UK headquartered...
OG of fast cars drops in games: Porsche adopts in-car gaming with AirConsole
Zurich, Aug. 28, 2025 (GLOBE NEWSWIRE) -- AirConsole, the pioneering in-car gaming platform that transforms car rides into shared entertainment experiences, is arriving in the new Porsche Macan later this year. This collaboration will bring a...
SEALSQ and Kaynes SemiCon Announce Joint Venture to Establish India's First Secure Semiconductor Center for Onshore Personalization and Quantum-Resistant Technology
Geneva, Switzerland / India, Sept. 29, 2025 (GLOBE NEWSWIRE) -- SEALSQ Corp (NASDAQ: LAES) ("SEALSQ" or "Company"), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology hardware and software products,,...
Oculis to Participate in Upcoming September Investor Conferences
ZUG, Switzerland, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on developing innovative solutions for ophthalmic and neuro-ophthalmic diseases with significant...
Industry Leaders Share Strategic Outlooks Ahead of the Scandinavian and Nordic Gaming Show 2025
STOCKHOLM, SWEDEN, September 30, 2025 /EINPresswire.com/ -- In three weeks, the highly anticipated 7th Annual Scandinavian & Nordic Gaming Show 2025 will assemble the region’s most influential regulators, operators, and technology leaders in...
Oculis Appoints Mark Kupersmith, M.D., and Sebastian Wolf, M.D., Ph.D., World-Renowned Neuro-Ophthalmology and Retina Experts, as Chief Medical Advisors
Mark Kupersmith, M.D. appointed as Chief Medical Advisor, Neuro-Ophthalmology, following positive Phase 2 ACUITY trial results with Privosegtor (OCS-05) in acute optic neuritis and initiation of multiple programs in neuro-ophthalmology Sebastian...
Advanz Pharma and Alvotech receive European approval for Mynzepli®, Biosimilar to Eylea®
Mynzepli® (aflibercept) is approved in all European Economic Area member countries for the treatment of various retinal diseases including neovascular (wet) age-related macular degeneration (AMD) Approval is based on comprehensive analytical,...
Alvotech Reports Results for the First Six Months of 2025 and Provides a Business Update
Strong performance driven by over 200% growth in product revenues year-on-year Best quarter in Alvotech’s history in terms of operating cash flows Continued expansion of commercial partnerships for pipeline assets Alvotech listed on Nasdaq...